Agilent Technologies, Frederick, CO, Onsite
Agilent Technologies Advanced Therapeutics Division (previously Nucleic Acids Solutions Division) is looking for a Process Validation Engineer to join their Process Validation team working at their state-of-the-art, contract Active Pharmaceutical Ingredient manufacturing facility that specializes in oligonucleotide chemistries located in Boulder and Frederick, Colorado.
As a Process Validation Engineer within the Process Validation team of Agilent's Advanced Therapeutics Division (ATD), the candidate will be responsible for executing process validation activities of oligonucleotide Active Pharmaceutical Ingredient (API) manufacturing. The responsibilities may include:
Control Strategies: Contribute knowledge and technical expertise to the development and refinement of manufacturing control strategies for oligonucleotide unit operations (examples: synthesis, deprotection, ultrafiltration, purification, annealing, concentration, lyophilization).
Stage 1 Assessments/Evaluations: Identify, assess, mitigate, and communicate process risks that may impact product quality, process performance, or regulatory compliance. Prepare and/or review process validation documentation including risk assessments, characterization plans/reports, technical assessments, control strategies, protocols, and summary reports.
Stage 1 Characterization: Perform or support process development studies. May include planning, executing, and analyzing Design of Experiments (DOE) and Proven Acceptable Range (PAR) experiments to support design space understanding and process validation as they relate to oligonucleotide upstream and downstream process operations.
Experiment Execution: Support laboratory scale experiment execution (occasional) to assess process risks and/or demonstrate robustness of process conditions. This may include set-up and operation of laboratory equipment. Document bench experiments in accordance with good documentation practices (GDP), analyze results, summarize findings, and provide recommendations based on outcomes.
Stage 2 CGMP Protocol Execution: Lead and/or support execution of process validation studies in a CGMP manufacturing setting.
PPQ and Commercial Support: Evaluate change controls associated with Process Performance Qualification (PPQ) or commercial processes. Evaluate process validation impact of nonconformances. Review commercial batch records to ensure alignment with Process Control Strategies.
Stage 3 CPV: Support continued process verification, which may include but is not limited to leading Continued Process Verification (CPV) plans, authoring CPV reports, and reviewing Product Quality Reports.
Lifecycle: Supports all areas of process validation from FDAs Product Lifecycle’s Stages 1, 2, and 3.
Communication: Provide process validation-related updates to clients and project teams in the form of slides, memos, and reports.
This job has a full time weekly schedule. Applications for this job will be accepted until at least July 1, 2026 or until the job is no longer posted.
No
Day
No End Date
R&D
Agilent customers are finding new ways to treat cancer, ensure food, water, air, and medicine quality and safety, discover new drug treatments, research infectious diseases, and create alternative energy solutions for a greener planet. From start to finish, we have them covered with our vast product solutions and services portfolio. Around the world, Agilent’s people bring innovations, technologies, and services to the forefront of science. Our teams design and manufacture a wide array of advanced analytical, research, and diagnostic solutions and tools for use inside and outside laboratories. Additionally, the unique expertise of Agilent’s CrossLab and technical teams provides valuable insight and support to our customers, helping them fully optimize their laboratories and resources to better focus on what's important: bringing great science to life. In fiscal 2022, Agilent Technologies generated revenue of (US) $6.85 billion.
View company profile →